Back to search results

Integrated Care for Opioid Use Disorder and Infectious Diseases in Veterans

This study is for U.S. Veterans with moderate to severe opioid use disorder (OUD) who are seeking treatment at the Northport VA substance use disorder clinic. It is testing a new approach called "Integrated Care." This means you would receive infectious disease testing (for HIV, Hepatitis C, gonorrhea, and chlamydia) and/or PrEP (pre-exposure prophylaxis for HIV) during the same clinic appointment where you receive OUD treatment. Currently, these services are often provided separately. Researchers want to see if combining these services makes it easier for Veterans to get tested for infectious diseases. The study aims to measure how many Veterans get screened for infectious diseases within 90 days of starting this integrated care.

Study design
This is an interventional study with a planned enrollment of 60 participants. It compares Integrated Care to usual care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, infectious diseases screening uptake, will be measured at 90 days during the intervention period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06766331

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

Not Yet Recruiting
NAAges 18+InterventionalScreening
VA Office of Research and Development
~60 participants
Updated 2026-04-24 on ClinicalTrials.gov
What's tested:Integrated care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Infectious diseases screening uptake during intervention period
Measured over 90 days

Conditions

Opioid Use Disorder
HIV
Hepatitis C Virus
Gonorrhea
Chlamydia
Syphilis
Sexually Transmitted Infection
Integrated Care
Medications for Opioid Use Disorder

Explore related trials

ChlamydiaGonorrheaHepatitis C InfectionHIV InfectionOpioid Use DisorderSyphilis

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Audun J Lier, MD · PRINCIPAL_INVESTIGATOR · Northport VA Medical Center, Northport, NY

Who to contact

Audun J Lier, MD
[email protected]
(631) 261-4400 · ext. 4827
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

US Veteran
Able to provide written informed consent in English
Living in the community (Nassau, Suffolk, Kings, Queens, Bronx, Westchester, Rockland counties, NY)
Documented diagnosis of moderate to severe opioid use disorder
Seeking care at the Northport VA substance use disorder clinic for opioid use disorder treatment
Willing to have HIV, HBV, HCV, or bacterial STI testing to determine negative or positive status
Persons who test negative for HIV need to meet CDC PrEP eligibility criteria in the 6 months prior to enrollment

Exclusion

Severe medical or psychiatric disability making participation unsafe
Unable to provide written consent
PrEP exclusion: HIV positive test; HBV positive test

What this trial measures

  • Infectious diseases screening uptake during intervention period90 days

    Proportion of Veterans who completed any screening for HIV, hepatitis C virus (HCV), gonorrhea, chlamydia, or syphilis during the intervention period